Heritage Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.7K Buy
1,100
+200
+22% +$11.7K ﹤0.01% 289
2025
Q4
$48.5K Hold
900
﹤0.01% 322
2025
Q3
$40.6K Hold
900
﹤0.01% 318
2025
Q2
$41.7K Hold
900
﹤0.01% 311
2025
Q1
$54.9K Hold
900
﹤0.01% 296
2024
Q4
$50.9K Hold
900
﹤0.01% 305
2024
Q3
$46.6K Sell
900
-1,170
-57% -$54.9K ﹤0.01% 333
2024
Q2
$86K Sell
2,070
-408
-16% -$18.3K ﹤0.01% 264
2024
Q1
$134K Sell
2,478
-1,188
-32% -$60.5K 0.01% 240
2023
Q4
$188K Buy
3,666
+1,287
+54% +$67.6K 0.01% 219
2023
Q3
$138K Sell
2,379
-203
-8% -$12.4K 0.01% 227
2023
Q2
$165K Sell
2,582
-35
-1% -$2.35K 0.01% 221
2023
Q1
$181K Sell
2,617
-218
-8% -$15.4K 0.01% 209
2022
Q4
$204K Buy
2,835
+700
+33% +$52.8K 0.01% 207
2022
Q3
$152K Buy
2,135
+33
+2% +$2.39K 0.01% 222
2022
Q2
$162K Sell
2,102
-64
-3% -$4.87K 0.01% 219
2022
Q1
$158K Sell
2,166
-1,700
-44% -$114K 0.01% 216
2021
Q4
$241K Hold
3,866
0.01% 193
2021
Q3
$229K Sell
3,866
-1,559
-29% -$103K 0.01% 188
2021
Q2
$362K Sell
5,425
-165
-3% -$10.8K 0.02% 154
2021
Q1
$353K Sell
5,590
-574
-9% -$35.7K 0.02% 161
2020
Q4
$382K Buy
6,164
+4,881
+380% +$300K 0.02% 150
2020
Q3
$77.4K Sell
1,283
-700
-35% -$42.1K 0.01% 233
2020
Q2
$117K Sell
1,983
-320
-14% -$19.1K 0.02% 188
2020
Q1
$128K Buy
2,303
+475
+26% +$29K 0.02% 162
2019
Q4
$117K Buy
1,828
+1,063
+139% +$60.9K 0.02% 215
2019
Q3
$38K Sell
765
-2,317
-75% -$109K 0.01% 300
2019
Q2
$140K Buy
3,082
+1,033
+50% +$48.1K 0.02% 169
2019
Q1
$97.8K Hold
2,049
0.02% 178
2018
Q4
$106K Sell
2,049
-112
-5% -$6.02K 0.02% 160
2018
Q3
$134K Buy
+2,161
New +$128K 0.03% 144
2016
Q3
Sell
-3,284
Closed -$241K 89
2016
Q2
$241K Buy
+3,284
New +$232K 0.16% 83

Other funds holding BMY

Heritage Wealth Advisors's BMY Position: Q1 2026 in Review

Heritage Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $11.7K and bringing the position to 1,100 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Heritage Wealth Advisors first reported a position in BMY in Q2 2016 and has held it in 32 quarters since. The position peaked at $382K in Q4 2020. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Heritage Wealth Advisors held 1,100 shares of Bristol-Myers Squibb worth $66.7K as of Q1 2026.
  • Heritage Wealth Advisors bought 200 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.7K.
  • Bristol-Myers Squibb made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #289 holding.
  • Heritage Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 32 quarters since.
  • Heritage Wealth Advisors's Bristol-Myers Squibb position peaked at $382K in Q4 2020.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.